483 Northland Nuclear Medicine Jun 2019

483 Northland Nuclear Medicine Jun 2019

Scott Golladay FDA, Anthony Ladner FDA$119.00 - Available Now

FDA investigators audited the Northland Nuclear Medicine - Bismarck, ND, United States facility and issued inspectional observations (via FDA 483) on 07 Jun 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Jun 2019
  • Location: Bismarck, United States
  • FEI: 3005334016
Add To Cart